SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-000866
Filing Date
2024-02-12
Accepted
2024-02-12 09:15:12
Documents
15
Period of Report
2024-02-12
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K xenetic_8k.htm   iXBRL 8-K 28944
  Complete submission text file 0001683168-24-000866.txt   242596

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE xbio-20240212.xsd EX-101.SCH 3728
3 XBRL DEFINITION FILE xbio-20240212_def.xml EX-101.DEF 26553
4 XBRL LABEL FILE xbio-20240212_lab.xml EX-101.LAB 36543
5 XBRL PRESENTATION FILE xbio-20240212_pre.xml EX-101.PRE 25177
16 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_8k_htm.xml XML 5357
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37937 | Film No.: 24617655
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)